Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -5 of 5 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care, Treatment				Active				18 to 75				Other				UMCN-AKF 07.02 EudraCTnr 2007-003347-73, NCT00588835


2.		Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				Other				2006-0961 NCT00542542


3.		A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				Pharmaceutical / Industry				NKV110721 NCT00601172

Last Modified: 11/10/2008 First Published: 1/25/2007


4.		Phase II Randomized Study of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients With Newly Diagnosed Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				8 to 18				NCI				HLMCC-0503 HLMCC 0503, NCT00429702

First Published: 11/19/2008


5.		Phase II Study of Ondansetron Hydrochloride for the Prevention of Dimethyl Sulfoxide-Related Nausea and Vomiting in Patients Receiving Cryopreserved Autologous Peripheral Blood Stem Cells

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				21 and over				NCI				FHCRC-2247.00 FHCRC-2247.00, IR-6765, NCT00795769

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute